Difference between revisions of "Desmopressin (DDAVP)"
(updated content) |
m |
||
| Line 19: | Line 19: | ||
[[Category:Hemostasis medications]] | [[Category:Hemostasis medications]] | ||
[[Category:Vasopressin analogs]] | [[Category:Vasopressin analogs]] | ||
| + | |||
| + | [[Category:Drugs FDA approved in 1978]] | ||
Revision as of 16:46, 3 November 2014
Also known as DesmoMelt, Minirin, or Stimate.
General information
Class/mechanism: Synthetic analog of vasopressin (ADH/antidiuretic hormone). In addition to its antidiuretic effects, also stimulates release of factor VIII and von Willebrand factor.[1][2][3][4][5][6]
Route: SC, IV, PO, intranasal
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1][3][5]
Patient drug information
- Desmopressin (DDAVP nasal) package insert pages 9-10[3]
- Desmopressin (DDAVP) patient drug information (UpToDate)[7]
References
- ↑ 1.0 1.1 Desmopressin (DDAVP tablet) package insert
- ↑ Desmopressin (DDAVP tablet) package insert (locally hosted backup)
- ↑ 3.0 3.1 3.2 Desmopressin (DDAVP nasal) package insert
- ↑ Desmopressin (DDAVP nasal) package insert (locally hosted backup)
- ↑ 5.0 5.1 Desmopressin (DDAVP injection) package insert
- ↑ Desmopressin (DDAVP injection) package insert (locally hosted backup)
- ↑ Desmopressin (DDAVP) patient drug information (UpToDate)